Speakers

David Silverman

Global Development Lead, Ophthalmology

Roche

Caroline Baumal

Professor of Ophthalmology and Director of Retinopathy

New England Eye Center

Ursula Schmidt

Scientific Advisor

RetInSight GmbH

Quentin Davis

VP of Operations

LKC Technologies

Jeff Jamison

Director In Vivo Pharmacology

Experimentica Ltd

Giedrius Kalesnykas

President & Chief Executive Officer

Experimentica

Ruchi Sharma

Staff Scientist

National Eye Institute

Kalliopi Stasi

SVP Clinical Development Adverum Biotechnologies

Adverum Biotechnologies

Abraham Scaria

Chief Scientific Officer

AGTC

Kip Connor

Head of Ophthalmology

Biogen

Stephen Poor

Director - External Innovation & Translational Biomarkers

Novartis AG

Michael Stewart

Professor and Chairman of Ophthalmology

Mayo Clinic

Daniel Chao

Senior Director - Translational, Experimental Medicine & Retina Clinical lead

Janssen Global Services, LLC

Arun Upadhyay

Chief Scientific Officer

Ocugen

David Tanzer

Chief Medical Officer

OcuTerra Therapeutics

Raj Singh Thakur

Professor of Pharmaceutics

Queen's University Belfast

Joel Naor

Chief Medical Officer

Opthea Limited

Brian Levy

Chief Executive Officer

Inflammx Therapeutics

Michael J Miller

Scientific Advisory Board

Glycadia Inc.

Alan Franklin

Founder

ForwardVue Pharma

Ivo Stoilov

Senior Director - Medical Affairs & Ophthalmology

Genentech Inc